Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
BMC Oral Health
|
December 9, 2023
Evaluation of two treatment concepts of four implants supporting fixed prosthesis in an atrophic maxilla: finite element analysis
Anlin Li, Zhixiang Mu, BaiRui Zeng, et al.
JAMA Network Open
|
June 13, 2020
Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
Yunfang Yu, Dagui Lin, Anlin Li, et al.
Medcomm
|
November 10, 2025
First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Wei Du, Anlin Li, Bijing Xiao, et al.
Clinical and Translational Medicine
|
November 2, 2020
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
Zifan He, Anlin Li, Dagui Lin, et al.
JAMA Network Open
|
April 8, 2020
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
Yunfang Yu, Wenda Zhang, Anlin Li, et al.
Optics Express
|
August 13, 2025
Using an optical scanning galvanometer to suppress image shift in a circumferential scanning detection system
Lin Wang, Anlin Li, Jingjie Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 9, 2024
Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
Yixin Zhou, Hui Yu, Chen Chen, et al.
JAMA Network Open
|
July 11, 2019
Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis
Yunfang Yu, Dongqiang Zeng, Qiyun Ou, et al.
JAMA Network Open
|
March 7, 2024
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis
Yixin Zhou, Anlin Li, Hui Yu, et al.
Immunologic Research
|
November 26, 2022
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
Linfeng Luo, Anlin Li, Sha Fu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
BMC Oral Health
|
December 9, 2023
Evaluation of two treatment concepts of four implants supporting fixed prosthesis in an atrophic maxilla: finite element analysis
Anlin Li, Zhixiang Mu, BaiRui Zeng, et al.
JAMA Network Open
|
June 13, 2020
Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
Yunfang Yu, Dagui Lin, Anlin Li, et al.
Medcomm
|
November 10, 2025
First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Wei Du, Anlin Li, Bijing Xiao, et al.
Clinical and Translational Medicine
|
November 2, 2020
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
Zifan He, Anlin Li, Dagui Lin, et al.
JAMA Network Open
|
April 8, 2020
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
Yunfang Yu, Wenda Zhang, Anlin Li, et al.
Optics Express
|
August 13, 2025
Using an optical scanning galvanometer to suppress image shift in a circumferential scanning detection system
Lin Wang, Anlin Li, Jingjie Wang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 9, 2024
Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
Yixin Zhou, Hui Yu, Chen Chen, et al.
JAMA Network Open
|
July 11, 2019
Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis
Yunfang Yu, Dongqiang Zeng, Qiyun Ou, et al.
JAMA Network Open
|
March 7, 2024
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis
Yixin Zhou, Anlin Li, Hui Yu, et al.
Immunologic Research
|
November 26, 2022
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
Linfeng Luo, Anlin Li, Sha Fu, et al.
Page
of 4